Propanc Biopharma authorizes $5M share buyback program; shares surge
Source: SeekingAlpha
2026-06-11 08:56:21 ET
More on Propanc Biopharma, Inc.
- Historical earnings data for Propanc Biopharma, Inc.
- Financial information for Propanc Biopharma, Inc.
Read the full article on Seeking Alpha
For further details see:
Propanc Biopharma authorizes $5M share buyback program; shares surge
Propanc Biopharma Inc.
NASDAQ: PPCB
PPCB Trading
-7.29% G/L:
$1.3999 Last:
99,326 Volume:
$1.50 Open:
PPCB Latest News
June 16, 2026 08:45:00 am
Propanc Biopharma's CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
June 11, 2026 12:09:00 pm
Clinical-Stage Biotech Rockets 308% After $5M Buyback and Phase 1 Cancer-Trial Path
$2,843,169
6,741,209
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
AU
Camberwell
